Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance

Tumors escape the immune system through many mechanisms. Here the authors show that certain tumors inhibit anti-tumor immunity by stopping the production of conventional dendritic cells (cDCs) in the bone marrow, therefore depleting the pool of cDCs available to present antigen to CD8+ T cells.

Guardado en:
Detalles Bibliográficos
Autores principales: Melissa A. Meyer, John M. Baer, Brett L. Knolhoff, Timothy M. Nywening, Roheena Z. Panni, Xinming Su, Katherine N. Weilbaecher, William G. Hawkins, Cynthia Ma, Ryan C. Fields, David C. Linehan, Grant A. Challen, Roberta Faccio, Rebecca L. Aft, David G. DeNardo
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/8ebabe15d49943d1834201842048ea26
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8ebabe15d49943d1834201842048ea26
record_format dspace
spelling oai:doaj.org-article:8ebabe15d49943d1834201842048ea262021-12-02T14:41:16ZBreast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance10.1038/s41467-018-03600-62041-1723https://doaj.org/article/8ebabe15d49943d1834201842048ea262018-03-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-03600-6https://doaj.org/toc/2041-1723Tumors escape the immune system through many mechanisms. Here the authors show that certain tumors inhibit anti-tumor immunity by stopping the production of conventional dendritic cells (cDCs) in the bone marrow, therefore depleting the pool of cDCs available to present antigen to CD8+ T cells.Melissa A. MeyerJohn M. BaerBrett L. KnolhoffTimothy M. NyweningRoheena Z. PanniXinming SuKatherine N. WeilbaecherWilliam G. HawkinsCynthia MaRyan C. FieldsDavid C. LinehanGrant A. ChallenRoberta FaccioRebecca L. AftDavid G. DeNardoNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-19 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Melissa A. Meyer
John M. Baer
Brett L. Knolhoff
Timothy M. Nywening
Roheena Z. Panni
Xinming Su
Katherine N. Weilbaecher
William G. Hawkins
Cynthia Ma
Ryan C. Fields
David C. Linehan
Grant A. Challen
Roberta Faccio
Rebecca L. Aft
David G. DeNardo
Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
description Tumors escape the immune system through many mechanisms. Here the authors show that certain tumors inhibit anti-tumor immunity by stopping the production of conventional dendritic cells (cDCs) in the bone marrow, therefore depleting the pool of cDCs available to present antigen to CD8+ T cells.
format article
author Melissa A. Meyer
John M. Baer
Brett L. Knolhoff
Timothy M. Nywening
Roheena Z. Panni
Xinming Su
Katherine N. Weilbaecher
William G. Hawkins
Cynthia Ma
Ryan C. Fields
David C. Linehan
Grant A. Challen
Roberta Faccio
Rebecca L. Aft
David G. DeNardo
author_facet Melissa A. Meyer
John M. Baer
Brett L. Knolhoff
Timothy M. Nywening
Roheena Z. Panni
Xinming Su
Katherine N. Weilbaecher
William G. Hawkins
Cynthia Ma
Ryan C. Fields
David C. Linehan
Grant A. Challen
Roberta Faccio
Rebecca L. Aft
David G. DeNardo
author_sort Melissa A. Meyer
title Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
title_short Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
title_full Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
title_fullStr Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
title_full_unstemmed Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance
title_sort breast and pancreatic cancer interrupt irf8-dependent dendritic cell development to overcome immune surveillance
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/8ebabe15d49943d1834201842048ea26
work_keys_str_mv AT melissaameyer breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT johnmbaer breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT brettlknolhoff breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT timothymnywening breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT roheenazpanni breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT xinmingsu breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT katherinenweilbaecher breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT williamghawkins breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT cynthiama breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT ryancfields breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT davidclinehan breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT grantachallen breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT robertafaccio breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT rebeccalaft breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
AT davidgdenardo breastandpancreaticcancerinterruptirf8dependentdendriticcelldevelopmenttoovercomeimmunesurveillance
_version_ 1718389943922851840